ROS-Targeted Depression Therapy Via BSA-Incubated Ceria Nanoclusters
Overview
Authors
Affiliations
Depression is one of the most fatal mental diseases, and there is currently a lack of efficient drugs for the treatment of depression. Emerging evidence has indicated oxidative stress as a key pathological feature of depression. We targeted reactive oxygen species (ROS) and synthesized CeO@BSA nanoclusters as a novel antidepression nanodrug a convenient, green, and highly effective bovine serum albumin (BSA) incubation strategy. CeO@BSA has ultrasmall size (2 nm) with outstanding ROS scavenging and blood-brain barrier crossing capacity, rapid metabolism, and negligible adverse effects and . CeO@BSA administration alleviates depressive behaviors and depression-related pathological changes of the chronic restraint stress-induced depressive model, suggesting promising therapeutic effects of CeO@BSA for the treatment of depression. Our study proved the validity by directly using nanodrugs as antidepression drugs instead of using them as a nanocarrier, which greatly expands the application of nanomaterials in depression treatment.
Interactions between ABC gene polymorphisms and processing speed in predicting depression severity.
Jin M, Ji L, Ran M, Bi Y, Zhang H, Tao Y BMC Psychiatry. 2025; 25(1):102.
PMID: 39910465 PMC: 11800503. DOI: 10.1186/s12888-025-06507-x.
Chang P, Ma J, Li K, Wang W, Chen D, Liu Z Mater Today Bio. 2024; 29:101357.
PMID: 39659840 PMC: 11629277. DOI: 10.1016/j.mtbio.2024.101357.
Light-activated nanoclusters with tunable ROS for wound infection treatment.
Wang X, Ding J, Chen X, Wang S, Chen Z, Chen Y Bioact Mater. 2024; 41:385-399.
PMID: 39184828 PMC: 11342113. DOI: 10.1016/j.bioactmat.2024.07.009.
Su F, Ye W, Shen Y, Xie Y, Zhang C, Zhang Q Adv Sci (Weinh). 2024; 11(36):e2402267.
PMID: 39049710 PMC: 11423151. DOI: 10.1002/advs.202402267.
Classification and application of metal-based nanoantioxidants in medicine and healthcare.
Nhat Nam N, Tran N, Nguyen T, Ngoc Trai N, Phuong Thuy N, Do H Beilstein J Nanotechnol. 2024; 15:396-415.
PMID: 38633767 PMC: 11022389. DOI: 10.3762/bjnano.15.36.